Poster: Tumor cell death caused by INT230-6 induces protective T cell immunity April 6, 2017 Poster presented at AACR 2017
Poster: Intratumoral injection of INT230-6 induces protective T cell immunity November 6, 2016 Poster presented at SITC 2016
Poster: A novel immunotherapy, INT230-6, is able to induce high rates of complete and durable response in mice through a cytotoxic T-cell-dependent mechanism April 18, 2016 Poster presented at AACR 2016
Poster: Novel Drug, INT230-6 shows strong synergy with anti-PD-1 Antibodies and can induce high complete response rates with T-cell memory response in a colon cancer mouse model November 11, 2015 Poster presented at SITC 2015
Poster: INT230-6, a Novel Intratumoral Anticancer Agent, is able to Eradicate Large Established Tumors and Stimulate Potent Antitumor Immunity April 19, 2015 Poster presented at AACR 2015
Poster: Novel cell penetrating formulation of cytotoxic agents administered intratumorally causes complete regression of large tumors and stimulation of an adaptive immune response in BALB/c syngeneic mice inoculated subcutaneously with murine CT26 colon cancer October 9, 2014 Poster presented at National Cancer Institute Immunology and Immunotherapy Meeting, October 2014